Joshua A Beckman Selected Research

Joshua A Beckman Research Topics

Disease

21	Peripheral Arterial Disease 02/2022 - 01/2008
13	Stroke (Strokes) 01/2021 - 05/2002
12	Hypertension (High Blood Pressure) 02/2022 - 05/2002
11	Myocardial Infarction 12/2021 - 05/2002
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 08/2010
9	Diabetes Mellitus 02/2022 - 01/2002
9	Atherosclerosis 01/2022 - 05/2002
7	Heart Failure 02/2022 - 03/2012
7	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 12/2011
6	Coronary Artery Disease (Coronary Atherosclerosis) 02/2022 - 07/2007
6	Insulin Resistance 11/2019 - 06/2006
6	Vascular Diseases (Vascular Disease) 01/2018 - 09/2003
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2003
5	Hemorrhage 11/2021 - 10/2004
5	Inflammation (Inflammations) 01/2020 - 11/2005
4	Ischemia 01/2022 - 01/2020
4	Obesity 01/2022 - 08/2013
4	COVID-19 12/2020 - 01/2020
4	Thrombosis (Thrombus) 12/2020 - 05/2002
4	Pulmonary Embolism 01/2020 - 06/2003
4	Hyperglycemia 08/2013 - 01/2002
3	Atrial Fibrillation 02/2022 - 10/2018
3	Venous Thromboembolism 01/2022 - 06/2003
3	Cognitive Dysfunction 01/2022 - 01/2018
3	Ischemic Stroke 12/2021 - 01/2018
3	Chronic Limb-Threatening Ischemia 01/2021 - 04/2008
3	Carotid Stenosis (Carotid Artery Stenosis) 01/2020 - 10/2013
2	Infections 01/2022 - 01/2018
2	Prediabetic State (Prediabetes) 01/2022 - 01/2018
2	Intermittent Claudication 11/2021 - 10/2019
2	Neoplasms (Cancer) 11/2021 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2018
2	Carotid Artery Diseases 01/2020 - 07/2009
2	Lipedema 01/2020 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2019 - 12/2004
2	Hyperemia 10/2018 - 08/2002
2	Chronic Renal Insufficiency 04/2008 - 01/2008
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2022
1	Viremia 01/2022
1	Frailty 12/2021
1	Arteriovenous Fistula 02/2021
1	Amyloidosis 01/2021
1	Neuroinflammatory Diseases 01/2021

Drug/Important Bio-Agent (IBA)

8	AndrogensIBA 01/2020 - 12/2011
5	LipidsIBA 01/2022 - 05/2007
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2005
4	BilirubinIBA 01/2018 - 01/2008
3	ApolipoproteinsIBA 01/2022 - 01/2018
3	RivaroxabanIBA 01/2022 - 11/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 10/2019
3	Pharmaceutical PreparationsIBA 11/2021 - 11/2004
3	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2018
3	Heparin (Liquaemin)FDA LinkGeneric 07/2020 - 06/2003
3	Clopidogrel (Plavix)FDA Link 07/2009 - 12/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2008 - 07/2004
3	Insulin (Novolin)FDA Link 05/2007 - 05/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2004 - 01/2002
2	Triglycerides (Triacylglycerol)IBA 02/2022 - 01/2021
2	HDL LipoproteinsIBA 02/2022 - 01/2021
2	oxidized low density lipoproteinIBA 01/2021 - 04/2015
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2020
2	AnticoagulantsIBA 12/2020 - 11/2019
2	Biological ProductsIBA 01/2020 - 01/2018
2	SodiumIBA 01/2020 - 01/2018
2	Nonesterified Fatty Acids (NEFA)IBA 11/2019 - 05/2007
2	AntioxidantsIBA 08/2015 - 12/2003
2	Protein Kinases (Protein Kinase)IBA 08/2010 - 01/2002
2	C-Reactive ProteinIBA 05/2007 - 11/2005
2	Glucose (Dextrose)FDA LinkGeneric 05/2007 - 06/2006
2	Warfarin (Coumadin)FDA LinkGeneric 10/2004 - 06/2003
1	CytokinesIBA 01/2022
1	efavirenz (Sustiva)FDA Link 01/2022
1	2-Aminoadipic Acid (2 Aminoadipic Acid)IBA 01/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Liver X ReceptorsIBA 01/2022
1	Emtricitabine (Emtriva)FDA Link 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2021
1	dicarboxydine (DCD)IBA 11/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	LDL CholesterolIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	NeurograninIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2020
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2020
1	glyoxylic acid (glyoxylate)IBA 01/2020

Therapy/Procedure

36	Therapeutics 01/2022 - 05/2002
9	Surgical Amputation (Amputations) 01/2022 - 05/2002
3	Exercise Therapy (Therapy, Exercise) 11/2021 - 01/2019
3	Brachytherapy 09/2015 - 03/2012
3	Secondary Prevention 07/2011 - 04/2008
2	Drug-Eluting Stents 10/2019 - 07/2007
2	Stents 10/2019 - 06/2017
2	Carotid Endarterectomy 01/2018 - 10/2013
2	Vascular Surgical Procedures 03/2012 - 11/2011
1	Kidney Transplantation 02/2021